Argan IncArgan posted strong Q1 fiscal 2027 revenue growth of 50% and a $2.8 billion backlog, indicating robust financial performance.
Zacks Investment Research has identified four top-ranked stocks with sound liquidity and strong growth potential that investors may consider to maximize returns. The four stocks are Alignment Healthcare, Argan, Agilysys, and Ciena Corporation. The screening used current, quick, and cash ratios between 1 and 3, asset utilization above the industry average, a Zacks Rank of 1, and a Growth Score of B or better, narrowing a universe of over 7,700 stocks to just 15. Alignment Healthcare reported first-quarter 2026 revenues of $1.24 billion, up 33.3% year over year, with health plan membership rising 30.9% to 284,800. Argan posted first-quarter fiscal 2027 revenues of $291 million, a 50% increase, and ended the quarter with a backlog of $2.8 billion. Agilysys delivered fiscal 2026 revenues of $319.3 million, up 15.9%, and guided fiscal 2027 revenues to $365–$370 million with subscription revenue growth north of 30%. Ciena's fiscal second-quarter 2026 revenues surged 39.5% to $1.57 billion, driven by cloud demand, and it expects third-quarter revenues of $1.625 billion.
Argan IncArgan posted strong Q1 fiscal 2027 revenue growth of 50% and a $2.8 billion backlog, indicating robust financial performance.
Agilysys IncAgilysys reported fiscal 2026 revenue growth of 15.9% and guided fiscal 2027 revenue higher with strong subscription growth.
Alignment Healthcare LLCAlignment Healthcare reported Q1 2026 revenue up 33.3% and health plan membership growth of 30.9%.
Ciena CorpCiena's fiscal Q2 2026 revenue surged 39.5% driven by cloud demand, with strong Q3 guidance.
Argan SA